Zydus Cadila says 'positive results' from phase 2 studies of COVID-19 drug Desidustat in Mexico

In June 2020, Zydus Cadila had received approval from Mexico's
regulatory authority Cofepris to test one of its lead research
candidate Desidustat in the management of COVID-19.

https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/zydus-cadila-says-positive-results-from-phase-2-studies-of-covid-19-drug-desidustat-in-mexico/articleshow/80444749.cms

Comments

Popular posts from this blog

CSIR-IGIB Research Project Posts Recruitment, Online Application Process

NISER PhD Program Admission 2020-21 (Winter Session)